-
Mast Therapeutics Announces Pricing Of Underwritten Public Offering
-
Mast Therapeutics (MSTX) to Offer Common Stock And Warrants
-
Mast Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
-
Roth Capital Starts Mast Therapeutics (MSTX) at Buy
-
Notable Analyst Rating Changes 11/17: (MTG) (PSX) (CHK) Upgraded; (NOK) (ODP) (WTSL) Downgraded
-
Pre-Open Stock Movers 11/17: (CLDX) (BHI) (AGN) Higher; (DWA) (GSAT) (HAL) Lower (more...)